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mono-quaternary steroid group which is used commonly in general anaesthesia for the facilitation
of endotracheal intubation and for maintenance of muscle relaxation. Rocuronium injection pain is
a signiﬁcant drawback with an incidence ranging from 50% to 80% [1,2]. Separation of children
from their parents and shifting them to the OT is an everyday problem to paediatric anaesthetists,
in our centre; majority of anaesthetists use IV midazolam to solve this problem, some anaesthetists
use IV ketamine hydrochloride instead. This randomized, double-blind study was designed to com-
pare the effect of IV ketamine versus IV midazolam in reducing rocuronium injection-related with-
drawal movements in paediatric patients.
Methods: Hundred and twenty paediatric patients aged 2–10 years subjected to urologic proce-
dures under general anaesthesia were randomly classiﬁed into two groups: the ketamine group in
which IV ketamine 1 mg kg1 was given and the midazolam group in which IV midazolam
0.05 mg kg1 was given before shifting the child to the operation room.268464.
oo.com (A.M. Shabana),
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142 A.M. Shabana, E.S. NasrResults: Ketamine showed a highly signiﬁcant reduction in the incidence of rocuronium injection-
related withdrawal movements in paediatric patients (P-value 0.000) compared to midazolam which
was ineffective.
Conclusion: This study demonstrated that ketamine effectively reduced pain after injection of rocu-
ronium in paediatric patients compared to midazolam which was ineffective, and both ketamine
and midazolam resolved peacefully the problem of child-parent separation before shifting to the
OR.
ª 2011 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.Table 1 Grading of withdrawal response [5].
Degree of
movement
Patient response
1 No response withdrawal
2 Movement at wrist only
3 Movement/ withdrawal involving arm only
4 Generalized response – withdrawal movement
in more than one extremity, cough, or breath
holding
Open access under CC BY-NC-ND license.1. Introduction
Rocuronium bromide is a non-depolarizing muscle relaxant re-
lated to mono-quaternary steroid group which is used com-
monly in general anaesthesia for facilitation of endotracheal
intubation and for maintenance of muscle relaxation. Rocuro-
nium injection pain is a signiﬁcant drawback with an incidence
ranging from 50% to 80% [1,2]. This pain was manifested in
conscious patients given a sub-paralysing dose by severe burn-
ing sensation and in unconscious patients by withdrawal
movements of the injected limb. The underlying mechanism
of such pain is unclear; however the signiﬁcant increase in his-
tamine and tryptase release from mast cells after rocuronium
injection and the resultant activation of perivascular nocicep-
tive nerve endings and poly-modal nociceptors in the wall of
the peripheral veins may explain rocuronium injection pain
[3,4].
Separation of children from their parents and shifting them
to the OT is an every day problem to paediatric anaesthetists,
in our centre; majority of anaesthetists use IV midazolam to
solve this problem, some anaesthetists use IV ketamine hydro-
chloride instead. This randomized, double-blind study was de-
signed to compare the effect of IV ketamine versus IV
midazolam in reducing rocuronium injection-related with-
drawal movements in paediatric patients subjected to elective
urologic surgeries under general anaesthesia.
2. Methods
This study was conducted in the Urology and Nephrology cen-
ter/Mansoura University Hospital/Egypt. Both institutional
committee approval and an informed consent from each par-
ent were taken. 120 children classiﬁed ASA1 and ASA2 (age
range 2–10 years) admitted for elective urologic procedures un-
der general anaesthesia were included. Children with known
history of allergy to rocuronium bromide, midazoalm, keta-
mine, and those having either difﬁcult cannulation (more than
two trials) or suspected difﬁcult intubation were excluded from
the study. Eligible patients were randomly allocated to one of
two equal groups (using computer generated-randomized test);
ketamine group (n= 60) and midazolam group (n= 60).
EMLA cream was applied for all children on the selected vein
on the dorsum of the hand and covered with gauze about 1 h
before shifting them to the main OT. In the waiting area of the
main OT a 22 G IV cannula was secured followed by IV
administration of glycopyrrolate (5 lg kg1) in addition to
midazolam (0.05 mg kg1) in the midazolam group or keta-
mine hydrochloride (1 mg kg1) intravenously. The calculated
dose of ketamine and midazolam was diluted with normal sal-
ine into 5 ml and given IV slowly by an anaesthetist while the
child was being held by his or her parents and once the childwas sedated he was placed supine on a trolley in accompani-
ment with both an anaesthetist and a nurse and shifted rapidly
to the operating room (OR).
On arrival to the OR, children were immediately monitored
with pulse oximetry, electrocardiograph, and non-invasive
arterial blood pressure; meanwhile child was preoxygenated
using a transparent face mask connected to Ayer T piece
breathing circuit with 100% oxygen. Capnograph was con-
nected after tracheal intubation. Oxygen desaturation deﬁned
by a ﬁrst reading of SpO2 less than 92% was recorded.
Both groups were subjected to the same anaesthetic man-
agement; diluted thiopental (1.25%) 3 mg kg1 was given
intravenously then followed by an IV injection of rocuronium
bromide 1 mg kg1 in approximately 30 seconds to facilitate
tracheal intubation. All children were intubated successfully
after 90 seconds with an appropriate sized endotracheal tube
followed by an IV administration of fentanyl (1 lg kg1). Chil-
dren were mechanically ventilated with air enriched oxygen
using a low-ﬂow closed circuit. After induction of anaesthesia,
the child was placed in lateral position and a lumbar epidural
analgesia with a ‘‘single shot’’ injection of a mixture of isobaric
bupivacaine 0.25% (0.8 mg kg1) and fentanyl (0.6 lg kg1)
was injected into lumbar 4–5 or 3–4 epidural spaces in order
to achieve both intraoperative and postoperative analgesia.
Anaesthesia was maintained with isoﬂurane in a concentration
of approximately 1% and air-enriched oxygen, increments of
rocuronium were given to maintain muscle relaxation, at the
end of surgery both atropine and neostigmine were adminis-
tered for reversal of muscle relaxant and all children were extu-
bated and shifted uneventfully to post-anaesthesia care unit.
To achieve study blindness, one of the anaesthetists (OR
anaesthetist) gave premedication; glycopyrrolate and keta-
mine/midazolam according to group randomization kept with
him, this anaesthetist prepared induction agents and rocuroni-
um according to the study protocol. A second anaesthetist who
was oblivious to group assignment injected both induction
agent and rocuronium and assessed rocuronium injection pain
objectively using the following withdrawal scale (Table 1).
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Package for the Social Sciences (SPSS for Windows, version
17). Based on previous investigations which reported an inci-
dence of rocuronium injection between 50% and 80% [1,2]
and assuming an average of 60% is the predicted incidence
of the current study, to detect 50% reduction in the incidence
of rocuronium injection pain at two-sided signiﬁcance level
0.050 and 90% power, it was calculated that a minimum of
58 patients was required in each study group. Normally dis-
tributed numerical data were presented by their mean and
standard deviation (SD), while in-between group differences
were compared parametrically using the independent-samples
Student t-test. Non-normally distributed numerical data were
presented as absolute number (percent or range), while inter-
group differences were compared non-parametrically using
the Mann–Whitney U test. Signiﬁcance level was set at
P< 0.050.
3. Results
In this study 5 patients in the ketamine group and 6 in the
midazolam group were rejected from the study because of
either difﬁcult cannulation or cannulation in a vein away from
the dorsum of the hand. Rejected patients were replaced
according to the group randomization. The group’s demo-
graphic data did not signiﬁcantly differ (Table 2). The inci-
dence of rocuronium withdrawal movements associated withTable 2 Demographic data.
Variable Ketamine group
(n= 60)
Midazolam group
(n= 60)
Age (years) 6.2 (1.7) 2–10 5.9 (1.8) 2–10
Weight (kg) 23 (0.5) 14–38 24 (0.4) 16–41
Gender (M/F) 48/12 51/9
Age and weight data are represented by mean (SD) range, while
gender is represented by absolute number, M=male, F = female
and n= number.
Table 3 Incidence and grade of withdrawal movement asso-
ciated with rocuronium injection in ketamine and midazolam
groups.
Withdrawal
movements
(4-point scale)
Ketamine
(n= 60)
Midazolam
(n= 60)
1 58 (96.7%) 11 (18.3%)
2 2 (3.3%) 14 (23.3%)
3 0 (0%) 19 (31.7%)
4 0 (0%) 16 (26.7%)
Overall incidence of pain 3.3%* 81.7%
Data are number of patients (%).
Withdrawal movements: 1 = no response, 2 = movement at wrist
only, 3 = movement involving arm only (elbow and shoulder),
4 = generalized movements in more than one extremity.
* P-value < 0.050 versus midazolam group (Mann–Whitney U
test).rocuronium injection in the ketamine group was 3.3% com-
pared to 81.7% in the midazolam group (P= 0.000). The inci-
dence of (grade 2) withdrawal movements in the ketamine
group was 3.3 compared to 23.3% in the midazolam group.
Ketamine group showed 0% in the incidence of withdrawal
movement grades-3 or -4 while the incidence of the movement
grade-3 and -4 in the midazolam group was 31.7% and 26.7%,
respectively (Table 3).
4. Discussion
In this study, we found that a bolus dose of IV ketamine
(1 mg kg1) signiﬁcantly prevented the withdrawal movements
associated with rocuronium injection when compared with IV
midazolam (0.05 mg kg1) in children subjected to elective
urologic surgical interventions under general anaesthesia.
The rapid onset (60–90 s) of rocuronium bromide at a dose
of 0.9–1.2 mg kg1 expands its use to be used in rapid-se-
quence intubation situations replacing succinylcholine [6] in
addition to its routine use to maintain muscle relaxation dur-
ing general anaesthesia. Unfortunately the high incidence of
rocuronium injection pain is a major drawback of this muscle
relaxant agent.
Rocuronium injection pain seems a minor problem that
does not need a lot of attention from anaesthesia society, how-
ever, the reported pulmonary aspiration secondary to gastric
regurgitation caused by generalized spontaneous movements
after the injection of rocuronium [7], increased the risk of ve-
nous catheter dislodgment which is sometimes considered a
major problem specially in case of difﬁcult cannulation like
in an obese child, in addition to the pain-related stress response
that can induce bronchospasm , tachycardia and hypertension
[8].
All the above makes rocuronium injection pain a consider-
able problem especially in paediatrics that deserves our atten-
tion to expand the ways for its solution.
Drugs like lidocaine [9], ondansetron [10], sodium bicar-
bonate and magnesium sulphate [11], also fentanyl and alfen-
tanil [10–12] and the dilutional effect of normal saline [13]
were used for alleviation of this pain.
Lidocaine and opioids (mainly fentanyl) are probably the
most commonly studied drugs to minimize rocuronium injec-
tion pain, mixing rocuronium with lidocaine gave rise to a
debate regarding its effect in reducing rocuronium injection
pain, some reported minimal effect and others reported a sig-
niﬁcant effect in this aspect [9,11].
The pretreatment administration with opioids like fentanyl
and alfentanil [10–12], was seen as a simple and effective meth-
od to decrease rocuronium injection pain, however Chiarella et
al. [14] found that mixing 100 lg fentanyl with rocuronium
was comparable to mixing normal saline with rocuronium
and both resulted in minimal reduction of rocuronium injec-
tion pain which was postulated as a dilutional effect. In their
study Chiarella et al. [14] found that despite both midazolam
1 mg and 100 lg fentanyl premedication was given to all pa-
tients, the rocuronium injection pain was high reaching 66%.
Ahmed et al. [11] compared lidocaine and fentanyl pretreat-
ment using tourniquet and found both were effective, on the
other hand, Memis et al. [10] compared ondanosteron, lido-
caine, tramadol and fentanyl with normal saline and reported
that all were effective in different degrees and lidocaine was the
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[15] studied compared the pretreatment effect of fentanyl,
sufentanil, lidocaine with normal saline on rocuronium injec-
tion pain and found that the incidence of pain after injection
of fentanyl, sufentanil and normal saline was comparable
and lidocaine signiﬁcantly reduced rocuronium injection pain
which agree with the result of Chiarella et al. [14].
In contrast to the debate around opioid like fentanyl and
sufentanil, Choi et al. [16], found remifentanil in a dose of
(1 lg kg1) decreased the incidence of rocuronium related
withdrawal movements from 70% in the saline group to 0%
in the remifentanil group.
Ketamine and midazolam alone or in combination are the
most commonly used drugs to separate children peacefully
from their parents before shifting them to the OR, up to our
knowledge no study compared the efﬁcacy of ketamine versus
miadazolam in reducing rocuronium injection pain or midazo-
lam effect on the reduction of pain.
Ketamine is an intravenous dissociative anaesthetic agent
related to phencyclidine group which works by antagonizing
N-methyl D-aspartate (NMDA) receptors, its analgesic effect
has become a piece of fact. Midazolam is one of the benzodi-
azepines which are used commonly for the purpose of seda-
tion, amnesia and induction of anaesthesia thorough binding
to benzodiazepine receptor in the cerebral cortex [17].
Liou et al. [18] found that a small dose of ketamine
(0.2 mg kg1) reduced the incidence of withdrawal movement
in paediatric patients from 83% in the saline group to 27%
in the ketamine group after injection of rocuronium. Ketamine
was used by Mahajan et al. [19] and they reported its efﬁcacy
in reducing rocuronium injection pain. The higher reduction in
the incidence of rocuronium injection pain compared to both
Liou and Mahajan studies could be explained by the higher
dose of ketamine in the current study.
On the other hand midazolam was ineffective, however, up
to our knowledge there is lack of data about the effect of
midazolam on rocuronium injection pain in paediatrics.
In conclusion, this study demonstrated that ketamine effec-
tively reduced pain after injection of rocuronium in paediatric
patients compared to midazolam which was ineffective. Both
ketamine and midazolam resolved peacefully the problem of
child-parent separation before shifting to the OR without vio-
lence or serious disorders; however, ketamine could be a better
option compared to midazolam in paediatric patients planned
to be given rocuronium bromide for the purpose of muscle
relaxation otherwise there is a contraindication to its use.
This study has some limitations including the absence of
placebo or control group which was obligatory for the purpose
of peaceful child-parent separation, absence of data about the
haemodynamic impacts of both ketamine and midazolam
especially on blood pressure and heart rate is another limita-
tion of this study.Acknowledgements
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